Every Sunday, we run a quick poll on the hottest subject in the Tobacco Industry. Hundreds of our Twitter/X followers vote, offering a collective wisdom on the subject matter or an immediate pulse on the market/industry developments.
Results of the Sunday polls:
What is your small-cap tobacco (nicotine) stock pick for 2026? (mcap: $2 billion or less)
– Turning Point Brands: 32%
– Scandinavian Tobacco: 29%
– Haypp: 26%
– Other: 13%
What would be the most consequential product portfolio event of 2026 in tobacco?
– on!/VELO Plus growth in the US: 42%
– IQOS ILUMA launch in the US: 29%
– VUSE One launch in the US: 17%
– International expansion of glo HILO & Ploom AURA: 12%
How did the Pre-close Trading Update affect your sentiment on British Amerian Tobacco (BAT)’s operational performance and financial delivery?
– It did not change: 67%
– Improved: 25%
– Lowered: 8%
What is your FY26 revenue & operating profit growth expectation for British Amerian Tobacco (BAT)?
– 3% revenue, 4% operating profit: 54%
– 5% revenue, 6% operating profit: 23%
– Lower than the mid-term range: 14%
– Higher than the mid-term range: 9%
Will British Amerian Tobacco (BAT) return to its mid-term growth algorithm (i.e. 3-5% revenue and mid-single digit operating profit growth) on a sustainable basis in 2026?
– Most likely: 50%
– For sure: 19%
– Difficult to tell: 17%
– No: 14%
Which tobacco company lags its competitors the most in terms of management quality?
– Altria: 56%
– Imperial Brands: 20%
– British American Tobacco: 16%
– Philip Morris International: 8%
What will you scrutinize first & foremost in Imperial Brands FY25 results (November 18, Tuesday)?
– FY26 Guidance: 48%
– U.S. Performance (Share-Volume-Pricing): 26%
– NGP Growth: 17%
– International Performance (Share-Volume-Pricing): 9%
What is a fair tobacco industry discount taking into account the regulatory restrictions and tax-driven uncertainties? P/E multiple —% less, compared to consumer goods companies with identical financial metrics.
– 0% (no discount): 34%
– 10%: 24%
– 20%: 30%
– 30% or more: 12%
PMI and Altria Q3 2025 results are ——- for BAT.
– Positive: 43%
– Neutral: 30%
– Negative: 18%
– Irrelevant: 9%
What is the most important piece of news you heard about PMI this week?
– ZYN U.S. pricing jeopardized: 44%
– FY25 EPS upped from $7.43-7.56 to $7.46-7.56: 20%
– Heated tobacco IMS growth down to 9%: 19%
– ZYN U.S. shipment 200+Mn cans: 17%
What will you scrutinize first & foremost in Altria Q3 2025 results (Oct 30, Thursday)?
– Cigarette volume/pricing: 35%
– New category performance (on!): 25%
– Strategic updates (NJOY re-launch, HnB PMTAs, international expansion): 25%
– Financials & FY25 Guidance: 15%
What will you scrutinize first & foremost in Philip Morris International Q3 2025 results (Oct 21, Tuesday)?
– ZYN volume/pricing: 50%
– Financials/Guidance (Revenue, EPS, operating margin, adjustments): 20%
– IQOS USA update: 15%
– Heated tobacco growth: 15%
Which tobacco company would you never invest in, regardless of how low the valuation is?
– Altria: 33%
– Japan Tobacco: 30%
– Imperial Brands: 27%
– British American Tobacco: 10%
Tobacco Pulse Surveys: Q3 2025
Tobacco Pulse Surveys: Q2 2025
Tobacco Pulse Surveys: Q1 2025
Tobacco Pulse Surveys: Q4 2024
Tobacco Pulse Surveys: Q3 2024
Tobacco Pulse Surveys: Q2 2024
